165 related articles for article (PubMed ID: 37943566)
21. Rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy, surgery, or "watch and wait".
Lai CL; Lai MJ; Wu CC; Jao SW; Hsiao CW
Int J Colorectal Dis; 2016 Feb; 31(2):413-9. PubMed ID: 26607907
[TBL] [Abstract][Full Text] [Related]
22. Feasibility study of a Response Surveillance Program in locally advanced mid and low rectal cancer to increase organ preservation.
Boubaddi M; Fleming C; Vendrely V; Frulio N; Salut C; Rullier E; Denost Q
Eur J Surg Oncol; 2023 Jan; 49(1):237-243. PubMed ID: 36114048
[TBL] [Abstract][Full Text] [Related]
23. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
[TBL] [Abstract][Full Text] [Related]
24. Adoption of Organ Preservation and Surgeon Variability for Patients with Rectal Cancer Does Not Correlate with Worse Survival.
Kim JK; Thompson H; Jimenez-Rodriguez RM; Wu F; Sanchez-Vega F; Nash GM; Guillem JG; Paty PB; Wei IH; Pappou EP; Widmar M; Weiser MR; Smith JJ; Garcia-Aguilar J
Ann Surg Oncol; 2022 Feb; 29(2):1172-1179. PubMed ID: 34601641
[TBL] [Abstract][Full Text] [Related]
25. The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy.
Wang QX; Zhang R; Xiao WW; Zhang S; Wei MB; Li YH; Chang H; Xie WH; Li LR; Ding PR; Chen G; Zeng ZF; Wang WH; Wan XB; Gao YH
Radiat Oncol; 2021 Jan; 16(1):16. PubMed ID: 33468176
[TBL] [Abstract][Full Text] [Related]
26. [A Case Report of Organ Preservation by Total Neoadjuvant Therapy and Local Excision for Lower Rectal Cancer].
Imaoka H; Ieki H; Yamashita S; Ichikawa T; Uratani R; Shimura T; Kitajima T; Kawamura M; Yasuda H; Okugawa Y; Morimoto Y; Okita Y; Yoshiyama S; Ohi M; Toiyama Y
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1866-1868. PubMed ID: 38303234
[TBL] [Abstract][Full Text] [Related]
27. Organ Preservation Among Patients With Clinically Node-Positive Rectal Cancer: Is It Really More Dangerous?
Habr-Gama A; São Julião GP; Vailati BB; Fernandez LM; Ortega CD; Figueiredo N; Gama-Rodrigues J; Perez RO
Dis Colon Rectum; 2019 Jun; 62(6):675-683. PubMed ID: 30870223
[TBL] [Abstract][Full Text] [Related]
28. Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer Therapy.
Chapman WC; Kim H; Bauer P; Makhdoom BA; Trikalinos NA; Pedersen KS; Glasgow SC; Mutch MG; Silviera ML; Roy A; Parikh PJ; Hunt SR
Dis Colon Rectum; 2022 Feb; 65(2):198-206. PubMed ID: 34990423
[TBL] [Abstract][Full Text] [Related]
29. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis.
Chadi SA; Malcomson L; Ensor J; Riley RD; Vaccaro CA; Rossi GL; Daniels IR; Smart NJ; Osborne ME; Beets GL; Maas M; Bitterman DS; Du K; Gollins S; Sun Myint A; Smith FM; Saunders MP; Scott N; O'Dwyer ST; de Castro Araujo RO; Valadao M; Lopes A; Hsiao CW; Lai CL; Smith RK; Paulson EC; Appelt A; Jakobsen A; Wexner SD; Habr-Gama A; Sao Julião G; Perez R; Renehan AG
Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):825-836. PubMed ID: 30318451
[TBL] [Abstract][Full Text] [Related]
30. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis.
Dossa F; Chesney TR; Acuna SA; Baxter NN
Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):501-513. PubMed ID: 28479372
[TBL] [Abstract][Full Text] [Related]
31. Treatment Options for Distal Rectal Cancer in the Era of Organ Preservation.
Wang C; Liu X; Wang W; Miao Z; Li X; Liu D; Hu K
Curr Treat Options Oncol; 2024 Apr; 25(4):434-452. PubMed ID: 38517596
[TBL] [Abstract][Full Text] [Related]
32. [Application value of colonoscopic assessment in "watch and wait" strategy for mid-lower rectal cancer after neoadjuvant chemoradiotherapy].
Li SJ; Wang L; Zhang XY; Li YH; Li ZW; Wu Q; Sun YS; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jul; 22(7):648-655. PubMed ID: 31302963
[No Abstract] [Full Text] [Related]
33. Transanal Endoscopic Microsurgery for Early Rectal Cancer: A Single-Center Experience.
O'Neill CH; Platz J; Moore JS; Callas PW; Cataldo PA
Dis Colon Rectum; 2017 Feb; 60(2):152-160. PubMed ID: 28059911
[TBL] [Abstract][Full Text] [Related]
34. [Organ preservation for rectal cancer: What are the arguments in favor of radiotherapy?].
Larrouy A; Giraud N; Huguet F; Vendrely V
Cancer Radiother; 2022 Oct; 26(6-7):766-770. PubMed ID: 35995720
[TBL] [Abstract][Full Text] [Related]
35. A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait Management.
Weiser MR; Chou JF; Kim JK; Widmar M; Wei IH; Pappou EP; Smith JJ; Nash GM; Paty PB; Cercek A; Saltz LB; Romesser PB; Crane CH; Garcia-Aguilar J; Schrag D; Gönen M
JAMA Netw Open; 2022 Sep; 5(9):e2233859. PubMed ID: 36173634
[TBL] [Abstract][Full Text] [Related]
36. Watch and Wait for rectal cancer in inflammatory bowel disease.
Azevedo JGM; Fernandez L; Herrando AI; Santiago I; Pares O; Parvaiz A
BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37429643
[TBL] [Abstract][Full Text] [Related]
37. Observation of "complete clinical response" in rectal cancer after neoadjuvant chemoradiation: The Flinders experience.
Sposato LA; Lam Y; Karapetis C; Vatandoust S; Roy A; Hakendorf P; Dwyer A; de Fontgalland D; Hollington P; Wattchow D
Asia Pac J Clin Oncol; 2018 Dec; 14(6):439-445. PubMed ID: 29932278
[TBL] [Abstract][Full Text] [Related]
38. Influence of Minimally Invasive Resection Technique on Sphincter Preservation and Short-term Outcome in Low Rectal Cancer in the Netherlands.
Rutgers ML; Detering R; Roodbeen SX; Crolla RM; Dekker JWT; Tuynman JB; Sietses C; Bemelman WA; Tanis PJ; Hompes R;
Dis Colon Rectum; 2021 Dec; 64(12):1488-1500. PubMed ID: 33990499
[TBL] [Abstract][Full Text] [Related]
39. Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.
Martens MH; Maas M; Heijnen LA; Lambregts DM; Leijtens JW; Stassen LP; Breukink SO; Hoff C; Belgers EJ; Melenhorst J; Jansen R; Buijsen J; Hoofwijk TG; Beets-Tan RG; Beets GL
J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27509881
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection.
Jawitz OK; Adam MA; Turner MC; Gilmore BF; Migaly J
Surgery; 2019 Jun; 165(6):1193-1198. PubMed ID: 30904173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
